The price of a drug should be based on its therapeutic benefits – not just what the market will bear
- Written by Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York

The U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs risks making new treatments...